152
Participants
Start Date
October 31, 2008
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
AZD6765
IV once per dosing day, multiple times during the treatment period
Placebo
0.9% saline IV once per dosing day multiple times during the treatment period
Research Site, Little Rock
Research Site, Los Angeles
Research Site, Orange
Research Site, San Diego
Research Site, Santa Ana
Research Site, Hartford
Research Site, New Haven
Research Site, Boca Raton
Research Site, Gainsville
Research Site, Hollywood
Research Site, Jacksonville
Research Site, Atlanta
Research Site, Roswell
Research Site, Hoffman Estates
Research Site, Joliet
Research Site, Overland Park
Research Site, Lake Charles
Research Site, Shreveport
Research Site, Haverhill
Research Site, St Louis
Research Site, Willingboro
Research Site, Albuquerque
Research Site, Rochester
Research Site, East Stroudsburg
Research Site, Philadelphia
Research Site, Austin
Research Site, Dallas
Lead Sponsor
AstraZeneca
INDUSTRY